Skip to Main Content

Paper Details

Efficacy of osimertinib against EGFRvIII+ glioblastoma.
Oncotarget
30
2020
Author NameAffiliation
David L CorcoranDuke University Medical Center
Rohan Ramakrishna
  • 1 - 2

Datasets

Release 1.2